Savant Capital LLC Has $210,000 Holdings in Encompass Health Co. (NYSE:EHC)

Savant Capital LLC cut its holdings in Encompass Health Co. (NYSE:EHC) by 4.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,279 shares of the company’s stock after selling 114 shares during the period. Savant Capital LLC’s holdings in Encompass Health were worth $210,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares during the last quarter. Avior Wealth Management LLC acquired a new stake in shares of Encompass Health in the third quarter valued at approximately $40,000. Tompkins Financial Corp acquired a new stake in shares of Encompass Health in the fourth quarter valued at approximately $46,000. Morse Asset Management Inc acquired a new stake in shares of Encompass Health in the third quarter valued at approximately $68,000. Finally, Point72 Asia Singapore Pte. Ltd. raised its holdings in shares of Encompass Health by 62.0% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 1,095 shares of the company’s stock valued at $106,000 after purchasing an additional 419 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on EHC. Royal Bank of Canada restated an “outperform” rating and set a $110.00 target price on shares of Encompass Health in a report on Tuesday, February 11th. KeyCorp boosted their target price on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Monday, February 10th. StockNews.com upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, February 15th. Barclays boosted their target price on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. Finally, Truist Financial restated a “buy” rating and set a $116.00 target price (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Ten equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $107.67.

Insider Activity

In other news, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.10% of the stock is currently owned by company insiders.

Encompass Health Price Performance

NYSE:EHC opened at $101.65 on Thursday. Encompass Health Co. has a one year low of $73.02 and a one year high of $104.55. The company has a market cap of $10.24 billion, a P/E ratio of 22.79, a P/E/G ratio of 2.33 and a beta of 0.90. The firm’s fifty day moving average price is $95.97 and its two-hundred day moving average price is $95.73. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Equities analysts expect that Encompass Health Co. will post 4.81 earnings per share for the current year.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.